AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (931 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

CARM1 accelerates the growth of liver cancer cells by enhancing ARAF

Xiaoxue Jianga,1, Libo Xinga,1, Yi Lub,1, Rushi Qina, Liyan Wanga, Shuting Songa, Xinlei Liua, Sijie Xiea, Shujie Lia, Dongdong Lua( )
Shanghai Putuo People’s Hospital, School of Life Science and Technology, Tongji University, Shanghai 200092, China
Departments of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).

1 These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 1,
January 2025
Article number: 101395
DOI: 10.1016/j.gendis.2024.101395

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Jiang X, Xing L, Lu Y, et al. CARM1 accelerates the growth of liver cancer cells by enhancing ARAF. Genes & Diseases, 2025, 12(1): 101395. https://doi.org/10.1016/j.gendis.2024.101395

640

Views

25

Downloads

1

Crossref

2

Web of Science

2

Scopus

0

CSCD
Received: 14 January 2024
Published: 23 August 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).